Truvada
From Wikipedia, the free encyclopedia
Truvada
|
|
Combination of | |
Tenofovir | Nucleotide analogue reverse transcriptase inhibitor |
Emtricitabine | Nucleoside reverse transcriptase inhibitor |
Identifiers | |
CAS number | ? |
ATC code | J05 |
PubChem | |
Therapeutic considerations | |
Pregnancy cat. |
B(US) |
Legal status | |
Routes | Oral |
Truvada is a fixed dose combination of two antiretroviral drugs used for the treatment of HIV. It consists of 300 milligrams of tenofovir and 200 milligrams of emtricitabine. By combining the two agents into one tablet, it reduces the pill burden and increases compliance with antiretroviral therapy. The drug has also found some potential as a preventative measure if taken before sex, though human clinical trials are ongoing [1].
A combination pill containing Truvada and efavirenz (Sustiva) is also available and is marketed as Atripla.
[edit] External links
- Truvada website, run by Gilead Sciences
|